590 related articles for article (PubMed ID: 17405660)
1. [New combination chemotherapy regimens in the primary treatment of operable breast cancer].
Conti F; Sergi D; Foggi P; Abbate MI; Lopez M
Clin Ter; 2007; 158(1):55-75. PubMed ID: 17405660
[TBL] [Abstract][Full Text] [Related]
2. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
Kaufmann M; Hortobagyi GN; Goldhirsch A; Scholl S; Makris A; Valagussa P; Blohmer JU; Eiermann W; Jackesz R; Jonat W; Lebeau A; Loibl S; Miller W; Seeber S; Semiglazov V; Smith R; Souchon R; Stearns V; Untch M; von Minckwitz G
J Clin Oncol; 2006 Apr; 24(12):1940-9. PubMed ID: 16622270
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy in breast cancer.
Charfare H; Limongelli S; Purushotham AD
Br J Surg; 2005 Jan; 92(1):14-23. PubMed ID: 15635596
[TBL] [Abstract][Full Text] [Related]
4. Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.
Piccart-Gebhart MJ; Burzykowski T; Buyse M; Sledge G; Carmichael J; Lück HJ; Mackey JR; Nabholtz JM; Paridaens R; Biganzoli L; Jassem J; Bontenbal M; Bonneterre J; Chan S; Basaran GA; Therasse P
J Clin Oncol; 2008 Apr; 26(12):1980-6. PubMed ID: 18421049
[TBL] [Abstract][Full Text] [Related]
5. [Does primary chemotherapy really increase the rate of breast conserving treatments?].
Hennequin C; Espié M; Misset JL; Maylin C
Cancer Radiother; 2004 Feb; 8(1):48-53. PubMed ID: 15093201
[TBL] [Abstract][Full Text] [Related]
6. [Primary chemotherapy in operable breast carcinoma].
Bonadonna G; Valagussa P
Ann Ital Chir; 1999; 70(3):359-69. PubMed ID: 10466239
[TBL] [Abstract][Full Text] [Related]
7. Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.
Solá M; Margelí M; Castellá E; Cirauqui B; Mariscal A; Rull M; Julian JF; Luna M; Vallejo V; Fraile M
Breast; 2013 Oct; 22(5):908-13. PubMed ID: 23683695
[TBL] [Abstract][Full Text] [Related]
8. Primary systemic therapy of breast cancer.
Sachelarie I; Grossbard ML; Chadha M; Feldman S; Ghesani M; Blum RH
Oncologist; 2006 Jun; 11(6):574-89. PubMed ID: 16794237
[TBL] [Abstract][Full Text] [Related]
9. Primary systemic chemotherapy for inflammatory breast cancer.
Sinclair S; Swain SM
Cancer; 2010 Jun; 116(11 Suppl):2821-8. PubMed ID: 20503414
[TBL] [Abstract][Full Text] [Related]
10. [Current trends in pharmacotherapy of breast cancer].
Boér K
Orv Hetil; 2002 Apr; 143(14):725-30. PubMed ID: 11975393
[TBL] [Abstract][Full Text] [Related]
11. Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials.
Cuppone F; Bria E; Carlini P; Milella M; Felici A; Sperduti I; Nisticò C; Terzoli E; Cognetti F; Giannarelli D
Cancer; 2008 Jul; 113(2):238-46. PubMed ID: 18470908
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy for locally advanced breast cancer.
Specht J; Gralow JR
Semin Radiat Oncol; 2009 Oct; 19(4):222-8. PubMed ID: 19732686
[TBL] [Abstract][Full Text] [Related]
13. Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design.
Alvarez RH; Hortobagyi GN
Breast Cancer Res Treat; 2010 Dec; 124(3):701-5. PubMed ID: 20953832
[No Abstract] [Full Text] [Related]
14. [Primary inoperable breast cancer].
Jørgensen J; Cold S; Kamby C
Ugeskr Laeger; 2007 Sep; 169(37):3091-3. PubMed ID: 17877956
[TBL] [Abstract][Full Text] [Related]
15. [Recent advance in adjuvant therapy for breast cancer].
Shimizu C; Watanabe T
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2458-69. PubMed ID: 12506467
[TBL] [Abstract][Full Text] [Related]
16. [Breast cancer].
Kobayashi T; Yamazaki H; Nakamura T; Ogihara A; Fujii T; Hirano A; Uno S; Yoshida K; Nagata T; Uchida K; Kubo H; Tozaki M; Kanehira C; Miyazawa Y; Suzuki M; Kuraishi Y
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1814-25. PubMed ID: 11729473
[TBL] [Abstract][Full Text] [Related]
17. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
Gralow JR; Burstein HJ; Wood W; Hortobagyi GN; Gianni L; von Minckwitz G; Buzdar AU; Smith IE; Symmans WF; Singh B; Winer EP
J Clin Oncol; 2008 Feb; 26(5):814-9. PubMed ID: 18258991
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatment for young women with early breast cancer.
Balduzzi A; Cardillo A; D'Alessandro C; Colleoni M
Minerva Ginecol; 2007 Oct; 59(5):513-27. PubMed ID: 17912178
[TBL] [Abstract][Full Text] [Related]
19. Preoperative (neoadjuvant) systemic treatment of breast cancer.
Kaufmann M; von Minckwitz G; Rody A
Breast; 2005 Dec; 14(6):576-81. PubMed ID: 16199160
[TBL] [Abstract][Full Text] [Related]
20. Current limits of knowledge in adjuvant and neoadjuvant endocrine therapy of breast cancer: the need for more clinical research.
Hayward RL; Dixon JM
Surg Oncol; 2003 Dec; 12(4):289-304. PubMed ID: 14998569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
